Clinical value of low power holmium laser enucleation in the treatment of prostate for benign prostatic hyperplasia
You Pinghong
Zhu Yanjie
Zhao Wenwu
Duan Xiaobo
Li Lingxun
Tan Rui
Abstract：Objective:To investigate the clinical value of low power holmium laser enucleation in the treatment of prostate for benign prostatic hyperplasia.Methods:312 patients with prostate for benign prostatic hyperplasia in our hospital during January 2012 to June 2015 were randomly divided into 2 groups;patients in the observation group (n =156) received low power holmium laser enucleation,and those in the control group (n =156) received transurethral resection of prostate.The operation time,removal weight of proliferation,postoperative serum Na +,blood Hb,complications,catheter indwelling time,hospital stay and postoperative maximum urinary flow rate (Qmax),International Prostate Symptom Score (IPSS),quality of life score (QOL),and serum prostate-specific antigen (PSA) were compared between the two groups.Results:The removal weight of proliferation,postoperative serum Na +,blood Hb,washing time after operation,complications,and hospital stay between the two groups were statistically significant (P＜0.05).The Q IPSS,QOL and PSA at 3rd,6th and 12th month after operation between the two groups showed no statistically significant differences (P ＜0.05).Conclusions:Low power holmium laser enucleation in the treatment of prostate for benign prostatic hyperplasia had similar efficacy to transurethral resection of prostate,and the former had the advantage of lower complication rate,so it was worthy of clinical application.
Keywords：low power holmium laser enucleationprostate for benign prostatic hyperplasiatransurethral resection of prostateclinical efficacy
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 309-311 )